FHTX
FHTX
NASDAQ · Biotechnology

Foghorn Therapeutics Inc

$4.76
+0.01 (+0.21%)
As of May 9, 1:54 AM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +509.0% upside
Low Target $18.54
Average Target $28.99
High Target $38.99
Current Price $4.76
Current
$4.76
Target
$28.99
$18.54 $28.99 avg $38.99
Scenario Analysis
Bear Case
$18.54
289.5%
Low target
Base Case
$28.99
+509.0%
Avg target
Bull Case
$38.99
+719.1%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$6.95
-31.5% from high
52-Week Low
$3.27
+45.6% from low
Target vs 52W High
$28.99
+317.1% vs high
Next Earnings Report
May 12, 2026 · Before Market Open
1d
tomorrow
EPS Est: $-0.30
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%